SEC Form 4 reporting owner

Stuelpnagel John R

Stuelpnagel John R has filed 6 Form 4 transactions reported between June 4, 2026 and September 3, 2026, as a reporting owner of 10x Genomics, Inc..

Name as filed: STUELPNAGEL JOHN R

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$2.4M
5 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 3, 2026
transaction date

Roles and reported holdings

  • TXG10x Genomics, Inc.
    Jun 4, 2026 – Sep 3, 2026

    Reporting owner

    Held directly328,436 sh as of Sep 3, 2026 · Form 4

    24 months: $2.4M sold

Transaction history

All 6 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 3, 2026TXGOpen-market saleCode S · direct6,174$387K@ $62.61Form 4
Sep 3, 2026TXGOpen-market saleCode S · direct6,814$423K@ $62.11Form 4
Sep 3, 2026TXGOpen-market saleCode S · direct7,012$425K@ $60.66Form 4
Aug 11, 2026TXGOpen-market saleCode S · direct3,000$176K@ $58.73Form 4
Aug 11, 2026TXGOpen-market saleCode S · direct17,000$979K@ $57.58Form 4
Jun 4, 2026TXGGrant or awardCode A · direct8,829—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.